The District of Columbia Department of Forensic Sciences Public Health Laboratory resent 409 samples back to the CDC for testing after discovering “calculation and formulation errors” may have occurred when processing some of the tests, according to a spokesperson for the lab. Of the 409 laboratory samples being retested, 294 were extracted from pregnant women. Thus far, two women who originally tested negative for Zika have now tested positive for the mosquito-borne virus.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox
“The CDC has prioritized these lab retests and, as they are completed, it is critical that patients are informed of the updated results so they can follow-up appropriately based on current clinical recommendations,” said Christopher Zahn, MD, vice president of practice activities for The American College of Obstetricians and Gynecologists, according to ABC News. “ACOG and the CDC have been in contact and continue to consult and collaborate and will issue any additional necessary information.”
The specimens being retested were obtained between July 14, 2016 and December 14, 2016.
More articles on the Zika virus:
Study: Zika virus persisted in semen for 3 months in 95% of men
Why does Zika cause birth defects while other similar viruses don’t? These researchers may know
Texas reports first case of a pregnant woman acquiring Zika locally
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
